Federal contract award

75N92B21F00001

STEMCELL TECHNOLOGIES INC:1109892 [21-001267] - THESE KITS ARE REQUIRED FOR ISOLATION OF DIFFERENT HUMAN PRIMARY IMMUNE CELLS (B CELLS, NK, NEUTROPHILS, MONOCYTES, CD4 T CELLS, CD8 T CELLS) FROM PATIENTS ENROLLED IN OUR CLINICAL STUDY

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NIAMS
NAICS541380 — Testing Laboratories and Services
PSC6505 — Drugs and Biologicals
Parent award / vehicleHHSN263201500148B
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$11.3K
Current contract value$11.3K
Potential contract value / ceiling$11.3K
Start dateMay 3, 2021
Current end dateMay 3, 2021
Potential end dateMay 3, 2021
Latest award activityJul 20, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 20, 2026P00001$-308STEMCELL TECHNOLOGIES INC:1109892 [21-001267] - THESE KITS ARE REQUIRED FOR ISOLATION OF DIFFERENT HUMAN PRIMARY IMMUNE CELLS (B CELLS, NK, NEUTROPHILS, MONOCYTES, CD4 T CELLS, CD8 T CELLS) FROM PATIENTS ENROLLED IN OUR CLINICAL STUDY
May 3, 20210$11.6KSTEMCELL TECHNOLOGIES INC:1109892 [21-001267] - THESE KITS ARE REQUIRED FOR ISOLATION OF DIFFERENT HUMAN PRIMARY IMMUNE CELLS (B CELLS, NK, NEUTROPHILS, MONOCYTES, CD4 T CELLS, CD8 T CELLS) FROM PATIENTS ENROLLED IN OUR CLINICAL STUDY

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.